Stocks MC Financial statements
Financial statementsMoelis & Co financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Moelis & Co files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating expenses | 452 | 520 | 659 | 632 | 678 | 1,045 | 769 | 895 | 1,022 | 1,243 |
| Operating income | 161 | 164 | 227 | 115 | 266 | 496 | 216 | -40.4 | 173 | 274 |
| Other non-operating income | 0.51 | 186 | 11.7 | 33 | 4.4 | 40.4 | 0.22 | 11.2 | 23.1 | 53.6 |
| Pre-tax income | 167 | 350 | 238 | 148 | 270 | 536 | 216 | -29.1 | 196 | 327 |
| Income tax | 24.8 | 224 | 30.4 | 11.8 | 51.7 | 113 | 47.6 | -1.63 | 44.5 | 67.9 |
| Net income to minority interests | 103 | 97.1 | 67.3 | 30.6 | 39.6 | 57.8 | 18.3 | -2.82 | 15.5 | 26.6 |
| Net income | 38.4 | 29.4 | 141 | 105 | 179 | 365 | 150 | -24.7 | 136 | 233 |
| EBITDA | 164 | 168 | 231 | 120 | 270 | 503 | 224 | -32 | 183 | 286 |
Balance sheet
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 319 | 213 | 261 | 168 | 202 | 520 | 207 | 186 | 412 | 509 |
| Short-term investments | 96.1 | 144 | 213 | 212 | 263 | 265 | ||||
| Property, plant and equipment | 8.4 | 10.5 | 12.7 | 14 | 50 | 59.2 | 57.2 | 63.8 | 65.5 | 89.8 |
| Lease right-of-use assets | 191 | 177 | 164 | 152 | 172 | 180 | 217 | |||
| Total assets | 599 | 699 | 914 | 1,072 | 1,196 | 1,556 | 1,217 | 1,180 | 1,379 | 1,741 |
| Total liabilities | 347 | 355 | 543 | 678 | 752 | 1,077 | 758 | 817 | 900 | 1,060 |
| Paid-in capital | 291 | 487 | 698 | 873 | 1,052 | 1,280 | 1,413 | 1,574 | 1,731 | 1,912 |
| Retained earnings | -68.2 | -140 | -238 | -324 | -421 | -535 | -561 | -768 | -822 | -801 |
| Treasury stock | -10.9 | -23.2 | -56.7 | -108 | -152 | -256 | -404 | -451 | -462 | -536 |
| Other comprehensive income | -0.54 | 0.35 | 0.29 | 1.43 | -0.2 | -0.56 | -4.53 | -3.93 | -6.73 | -7.12 |
| Shareholders' equity | 212 | 325 | 404 | 443 | 480 | 489 | 444 | 352 | 442 | 568 |
| Minority interests | 39.6 | 19.3 | -32.6 | -49 | -35.5 | -10.8 | 14.4 | 10.3 | 37.8 | 112 |
| Total equity | 251 | 344 | 372 | 394 | 444 | 478 | 459 | 362 | 479 | 680 |
| Total liabilities and equity | 599 | 699 | 914 | 1,072 | 1,196 | 1,556 | 1,217 | 1,180 | 1,379 | 1,741 |
Cash flow statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 142 | 127 | 208 | 136 | 218 | 423 | 169 | -27.5 | 151 | 260 |
| Depreciation and amortization | 3.18 | 3.54 | 4.63 | 4.97 | 4.71 | 7.24 | 7.98 | 8.32 | 10.4 | 11.9 |
| Stock-based compensation | 77.1 | 96.3 | 123 | 124 | 134 | 168 | 129 | 158 | 161 | 230 |
| Deferred income tax | -1.01 | 192 | 6.54 | 3.67 | 39 | 22.9 | 26.8 | -4.29 | 35.1 | 50 |
| Change in receivables | 5.54 | -35.6 | 0.96 | 7.06 | -46.7 | 26.9 | -20.3 | -4.01 | -1.84 | -31.2 |
| Change in payables | -6.22 | 3.61 | 1.69 | |||||||
| Cash from operations | 232 | 233 | 391 | 209 | 429 | 937 | 33 | 158 | 427 | 576 |
| Capital expenditures | -2.87 | -5.65 | -6.92 | -6.47 | -40.7 | -16.4 | -5.96 | -16.7 | -12.1 | -36.3 |
| Purchases of investments | -121 | -180 | -184 | -212 | -391 | -486 | -335 | -211 | -169 | -525 |
| Sales and maturities of investments | 126 | 116 | 200 | 120 | 391 | 456 | 333 | 276 | 188 | 336 |
| Cash from investing | 1.38 | -69.4 | 9.28 | -51.9 | -40 | -17 | -11.2 | 48.6 | 17.1 | -196 |
| Stock issued | 6.06 | 6.85 | 21.5 | 11.9 | ||||||
| Share buybacks | -3.31 | -0.23 | -0.29 | |||||||
| Dividends paid | -155 | -256 | -314 | -209 | -283 | -480 | -175 | -182 | -184 | |
| Cash from financing | -158 | -273 | -352 | -253 | -352 | -603 | -327 | -229 | -215 | -284 |
| Exchange rate effect | -4.2 | 3.07 | -0.56 | 2.06 | -2.76 | 0.31 | -8.39 | 1.8 | -3.53 | -0.24 |
| Net change in cash | 70.7 | -106 | 47.9 | -93.2 | 34.7 | 318 | -313 | -20.3 | 226 | 96.2 |
| Free cash flow | 229 | 228 | 384 | 203 | 389 | 921 | 27 | 142 | 415 | 540 |
| Income taxes paid | 28.6 | 31.8 | 23.5 | 13.4 | -0.31 | 55.2 | 76.4 | -3.63 | 2.62 | 9.3 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Effective tax rate | 24.9% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 45.1% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 16.2% | Net income / average total assets. |
| Return on invested capital (ROIC) | 72.9% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Operating income growth, 1y | 58.4% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 8.2% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | 0.6% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 55.8% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 8.4% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 1.1% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | 71.3% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 15.7% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | 5.4% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 34.8% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 159.5% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 6.1% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 30.0% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 171.3% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 6.8% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 28.7% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 8.5% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 3.4% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 26.2% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 12.7% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 7.8% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Liabilities / assets | 54.4% | Total liabilities / total assets. |
| Tangible book value | $505.8M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| FCF conversion | 189.9% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 11.2% | Capital expenditures / cash from operations, when that is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $4.60B | Share price x shares outstanding. |
| Enterprise value | $4.39B | Market cap + total debt - cash - short-term investments. |
| P/E | 20.1x | Market cap / net income. Only when net income is positive. |
| P/B | 9.09x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 9.09x | Market cap / tangible book value, when positive. |
| P/FCF | 10.6x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 9.41x | Market cap / cash from operations, when positive. |
| EV/EBIT | 15.2x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 14.5x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 10.1x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 9.4% | Free cash flow / market cap. |
| Earnings yield | 5.0% | Net income / market cap (the inverse of P/E). |
Was Moelis & Co profitable in fiscal 2025?
Yes. Net income was $233.0M, a net margin of -.
How much free cash flow did Moelis & Co generate in fiscal 2025?
Cash from operations of $576.3M minus capital expenditures of $36.3M left free cash flow of $540.0M.